Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer

Published:2021-05-17 Issue:10 Volume:131 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Liu Deli^ORCID,Augello Michael A.,Grbesa Ivana,Prandi Davide^ORCID,Liu Yang^ORCID,Shoag Jonathan E.,Karnes R. Jeffrey,Trock Bruce J.^ORCID,Klein Eric A.^ORCID,Den Robert B.,Demichelis Francesca^ORCID,Davicioni Elai^ORCID,Sboner Andrea^ORCID,Barbieri Christopher E.^ORCID

Funder

National Cancer Institute

Urology Care Foundation

Damon Runyon Cancer Research Foundation

Prostate Cancer Foundation

U.S. Department of Defense

Foundation AIRC

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/147878/files/pdf

Reference65 articles.

1. Integrative Genomic Profiling of Human Prostate Cancer

2. The genomic complexity of primary human prostate cancer

3. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

4. The Molecular Taxonomy of Primary Prostate Cancer

5. The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing Prostate Cancer Care: Treatment Approaches to Precision Medicine, Biomarker Innovations, and Equitable Access;American Society of Clinical Oncology Educational Book;2024-06

2. ProstaMine: a bioinformatics tool for identifying subtype-specific co-alterations associated with aggressiveness in prostate cancer;Frontiers in Pharmacology;2024-05-01

3. Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysis;European Urology Oncology;2024-05

4. Quantification and molecular correlates of tertiary lymphoid structures in primary prostate cancer;The Prostate;2024-03-27

5. Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer;Virchows Archiv;2023-11-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3